Session Abstract – PMWC 2022 Silicon Valley

 Session Chair Profile

SVP Business Development & Strategy, Canexia Health

Brady heads business development, market development and strategy for Canexia Health where we make high-quality cancer genomic information accessible and affordable with our clinically validated assays, informatics, and support. As part of the Executive Management Team, Brady's responsibilities include developing and managing all Business Development and Market Development activities as well as Partnerships and Joint Ventures. Brady works closely with the CEO to set the companies 3-year strategy and keep the company on track to execute to plan. Prior to Canexia Health Brady lead strategy, market development and marketing for DNAnexus. Brady was responsible for building strategic partnerships with both technology and services-based organizations and as a member of the Executive Team is responsible for setting corporate strategy, running corporate development and innovation activities. Prior to DNAnexus Brady was head of strategy and market development for Illumina with a special focus on Informatics.

 Speaker Profile

Ph.D., Co-founder and CEO, CGI (Center for Genomic Interpretation)

Dr. Eggington advises policy makers on precision medicine, and is a contributing member of numerous committees, including the CDC/FDA/CMS Next Generation Sequencing Best Practices Forum. She oversees CGI's ELEVATEGENETICS initiative, which helps health insurance payers identify the more accurate and clinically efficacious genetic and genomic tests. Dr. Eggington directed programs at Myriad Genetics, Courtagen, and 23andMe prior to co-founding a genetic diagnostics consultancy company in 2016. The need for a disruptive nonprofit organization became clear through this consulting work, and Dr. Eggington co-founded CGI in 2017. She was a 2019 Sego Award winner for Utah women co-founders/CEOs in Innovation in Technology. Dr. Eggington also holds an affiliate faculty position at Brigham Young University.